<HashMap><database>ENA</database><scores/><additional><omics_type>Genomics</omics_type><center_name>Immunology &amp; Microbiology, Medical University of South Carolina</center_name><full_dataset_link>https://www.ebi.ac.uk/ena/browser/view/PRJNA432157</full_dataset_link><scientific_name>Homo sapiens</scientific_name><long_description>HIV-infected subjects were stratified to two groups high IgG anti-CD4 antibodies and low IgG anti-CD4 antibodies on day 14 (D14) after (“high” ≥ 2-fold increase from baseline “low” &lt; 2-fold increase) Overall design: HIV+ subject received the influenza vaccine, we draw the blood at the D0 and D7 of vaccination. Total RNA from purified B cells of PBMC was extracted using RNeasy Micro kit . Affymetrix Human GeneChip U133 Plus 2.0 Array was used for RNA hybridization and labeling assay.</long_description><tag>xref:PubMed:37138358</tag><repository>ENA</repository></additional><is_claimable>false</is_claimable><name>Expression data from different levels of anti-CD4 in HIV+ people</name><description>Expression data from different levels of anti-CD4 in HIV+ people</description><dates><last_updated>2025-09-24</last_updated><first_public>2019-01-03</first_public></dates><accession>PRJNA432157</accession><cross_references><GEO>GSE109837</GEO><taxon>9606</taxon><PubMed>37138358</PubMed></cross_references></HashMap>